Zhao SH, Zhu ZM, Yang T, Gao D, et al. Rituximab, high-dose methotrexate plus orelabrutinib as induction therapy in newly diagnosed primary central nervous system lymphoma. Leukemia 2025 Jul 12. doi: 10.1038/s41375-025-02658.
PMID: 40652061